CS logo
small CS logo
UMC Utrecht; Polkliniek Neuromusculaire ziekten

Utrecht, Netherlands

About UMC Utrecht; Polkliniek Neuromusculaire ziekten


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Total Rows: 1

Clinical Trials at UMC Utrecht; Polkliniek Neuromusculaire ziekten


During the past decade, UMC Utrecht; Polkliniek Neuromusculaire ziekten conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)
2014-11-01
2015-07-01
Terminated
9
A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)
2016-01-20
2018-12-18
Completed
131
A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy
2017-03-03
2024-12-27
Active, not recruiting
174

Rows per page:

1–3 of 3

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at UMC Utrecht; Polkliniek Neuromusculaire ziekten


According to Clinical.Site data, the most researched conditions in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" are "Muscular Atrophy, Spinal" (2 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" in a lesser frequency.

Clinical Trials Intervention Types at UMC Utrecht; Polkliniek Neuromusculaire ziekten


Most popular intervention types in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Olesoxime" (1 trials), "RO6885247" (1 trials), "Risdiplam" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UMC Utrecht; Polkliniek Neuromusculaire ziekten


The vast majority of trials in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" are 3 trials for "All" genders.

Clinical Trials Status at UMC Utrecht; Polkliniek Neuromusculaire ziekten


Currently, there are NaN active trials in "UMC Utrecht; Polkliniek Neuromusculaire ziekten". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UMC Utrecht; Polkliniek Neuromusculaire ziekten, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UMC Utrecht; Polkliniek Neuromusculaire ziekten, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1Terminated: 1Terminated: 1